Advertisement
Advertisement

INFU

INFU logo

InfuSystem Holdings, Inc.

12.49
USD
Sponsored
+0.62
+5.22%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

12.09

-0.40
-3.20%

INFU Earnings Reports

Positive Surprise Ratio

INFU beat 15 of 25 last estimates.

60%

Next Report

Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$38.02M
/
$0.13
Implied change from Q2 26 (Revenue/ EPS)
+2.95%
/
-13.33%
Implied change from Q3 25 (Revenue/ EPS)
+4.20%
/
+18.18%

InfuSystem Holdings, Inc. earnings per share and revenue

On Aug 04, 2026, INFU reported earnings of 0.15 USD per share (EPS) for Q2 26, beating the estimate of 0.10 USD, resulting in a 40.06% surprise. Revenue reached 36.93 million, compared to an expected 37.08 million, with a -0.40% difference. The market reacted with a +33.62% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of 0.13 USD, with revenue projected to reach 38.02 million USD, implying an decrease of -13.33% EPS, and increase of 2.95% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
logo
BioLife Solutions Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
logo
Trulieve Cannabis Corp.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.06
Actual
$0.11
Surprise
+72.14%
logo
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
logo
Apyx Medical Corporation Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+16.27%
logo
ResMed Inc.
Report Date
Aug 06, 2026 For Q4 26
Estimate
$2.91
Actual
$2.95
Surprise
+1.09%
logo
Lantheus Holdings, Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.31
Actual
$1.55
Surprise
+17.50%
logo
ICU Medical Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.95
Actual
$2.37
Surprise
+21.43%
logo
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
logo
United-Guardian, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-
Actual
$0.16
Surprise
-
FAQ
For Q2 2026, InfuSystem Holdings, Inc. reported EPS of $0.15, beating estimates by 40.06%, and revenue of $36.93M, -0.4% below expectations.
The stock price moved up 33.62%, changed from $9.22 before the earnings release to $12.32 the day after.
The next earning report is scheduled for Nov 02, 2026.
Based on 7 analysts, InfuSystem Holdings, Inc. is expected to report EPS of $0.13 and revenue of $38.02M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement